These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1324 related articles for article (PubMed ID: 21057493)

  • 21. Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice.
    Ko M; Bandukwala HS; An J; Lamperti ED; Thompson EC; Hastie R; Tsangaratou A; Rajewsky K; Koralov SB; Rao A
    Proc Natl Acad Sci U S A; 2011 Aug; 108(35):14566-71. PubMed ID: 21873190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies.
    Bacher U; Haferlach C; Schnittger S; Kohlmann A; Kern W; Haferlach T
    Ann Hematol; 2010 Jul; 89(7):643-52. PubMed ID: 20195608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MBD3L2 promotes Tet2 enzymatic activity for mediating 5-methylcytosine oxidation.
    Peng L; Li Y; Xi Y; Li W; Li J; Lv R; Zhang L; Zou Q; Dong S; Luo H; Wu F; Yu W
    J Cell Sci; 2016 Mar; 129(5):1059-71. PubMed ID: 26769901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TET2-Mediated Spatiotemporal Changes of 5-Hydroxymethylcytosine During Organogenesis in the Late Mouse Fetus.
    Li X; Xie F; Jin J; Wu Y; Luo Z; Zhang F; Zhang S; Chen D; Liu A
    Anat Rec (Hoboken); 2019 Jun; 302(6):954-963. PubMed ID: 30369084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical loss of 5-hydroxymethylcytosine expression in acute myeloid leukaemia: relationship to somatic gene mutations affecting epigenetic pathways.
    Magotra M; Sakhdari A; Lee PJ; Tomaszewicz K; Dresser K; Hutchinson LM; Woda BA; Chen BJ
    Histopathology; 2016 Dec; 69(6):1055-1065. PubMed ID: 27458708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Classification of Acute Myeloid Leukemia by Cell-Free DNA 5-Hydroxymethylcytosine.
    Shao J; Shah S; Ganguly S; Zu Y; He C; Li Z
    Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias.
    Itzykson R; Kosmider O; Cluzeau T; Mansat-De Mas V; Dreyfus F; Beyne-Rauzy O; Quesnel B; Vey N; Gelsi-Boyer V; Raynaud S; Preudhomme C; Adès L; Fenaux P; Fontenay M;
    Leukemia; 2011 Jul; 25(7):1147-52. PubMed ID: 21494260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxylation of 5-methylcytosine by TET2 maintains the active state of the mammalian HOXA cluster.
    Bocker MT; Tuorto F; Raddatz G; Musch T; Yang FC; Xu M; Lyko F; Breiling A
    Nat Commun; 2012 May; 3():818. PubMed ID: 22569366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tet methylcytosine dioxygenase 2 inhibits atherosclerosis via upregulation of autophagy in ApoE-/- mice.
    Peng J; Yang Q; Li AF; Li RQ; Wang Z; Liu LS; Ren Z; Zheng XL; Tang XQ; Li GH; Tang ZH; Jiang ZS; Wei DH
    Oncotarget; 2016 Nov; 7(47):76423-76436. PubMed ID: 27821816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele.
    Bacher U; Weissmann S; Kohlmann A; Schindela S; Alpermann T; Schnittger S; Kern W; Haferlach T; Haferlach C
    Br J Haematol; 2012 Jan; 156(1):67-75. PubMed ID: 22017486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies.
    Li Z; Cai X; Cai CL; Wang J; Zhang W; Petersen BE; Yang FC; Xu M
    Blood; 2011 Oct; 118(17):4509-18. PubMed ID: 21803851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TET2- and TDG-mediated changes are required for the acquisition of distinct histone modifications in divergent terminal differentiation of myeloid cells.
    Garcia-Gomez A; Li T; Kerick M; Català-Moll F; Comet NR; Rodríguez-Ubreva J; de la Rica L; Branco MR; Martín J; Ballestar E
    Nucleic Acids Res; 2017 Sep; 45(17):10002-10017. PubMed ID: 28973458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic Leukemia.
    Yamazaki J; Jelinek J; Lu Y; Cesaroni M; Madzo J; Neumann F; He R; Taby R; Vasanthakumar A; Macrae T; Ostler KR; Kantarjian HM; Liang S; Estecio MR; Godley LA; Issa JP
    Cancer Res; 2015 Jul; 75(14):2833-43. PubMed ID: 25972343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TET2 and MEG3 promoter methylation is associated with acute myeloid leukemia in a Hainan population.
    Yao H; Duan M; Lin L; Wu C; Fu X; Wang H; Guo L; Chen W; Huang L; Liu D; Rao R; Wang S; Ding Y
    Oncotarget; 2017 Mar; 8(11):18337-18347. PubMed ID: 28407691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consequences of mutant TET2 on clonality and subclonal hierarchy.
    Hirsch CM; Nazha A; Kneen K; Abazeed ME; Meggendorfer M; Przychodzen BP; Nadarajah N; Adema V; Nagata Y; Goyal A; Awada H; Asad MF; Visconte V; Guan Y; Sekeres MA; Olinski R; Jha BK; LaFramboise T; Radivoyevitch T; Haferlach T; Maciejewski JP
    Leukemia; 2018 Aug; 32(8):1751-1761. PubMed ID: 29795413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined deficiency of Tet1 and Tet2 causes epigenetic abnormalities but is compatible with postnatal development.
    Dawlaty MM; Breiling A; Le T; Raddatz G; Barrasa MI; Cheng AW; Gao Q; Powell BE; Li Z; Xu M; Faull KF; Lyko F; Jaenisch R
    Dev Cell; 2013 Feb; 24(3):310-23. PubMed ID: 23352810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A role for
    Barazeghi E; Gill AJ; Sidhu S; Norlén O; Dina R; Palazzo FF; Hellman P; Stålberg P; Westin G
    Endocr Relat Cancer; 2017 Jul; 24(7):329-338. PubMed ID: 28642344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TET2 regulates extranodal NK/T cell lymphoma progression through regulation of DNA methylation.
    Xiang C; Gao L; Tao Q; Chen Z; Zhao S; Liu W
    Hematol Oncol; 2024 Jul; 42(4):e3295. PubMed ID: 38979860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia.
    Yamazaki J; Taby R; Jelinek J; Raynal NJ; Cesaroni M; Pierce SA; Kornblau SM; Bueso-Ramos CE; Ravandi F; Kantarjian HM; Issa JP
    J Natl Cancer Inst; 2015 Nov; 108(2):. PubMed ID: 26568194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetylation Enhances TET2 Function in Protecting against Abnormal DNA Methylation during Oxidative Stress.
    Zhang YW; Wang Z; Xie W; Cai Y; Xia L; Easwaran H; Luo J; Yen RC; Li Y; Baylin SB
    Mol Cell; 2017 Jan; 65(2):323-335. PubMed ID: 28107650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 67.